Colombia’s Superintendence for Industry and Commerce (SIC) has issued a fine to Chilean drug-store chain Cruz Verde after the company jacke dup the price of 56 separate medications by up to 3000%, far beyond the maximum prices set by the country’s authorities.
Colombian authorities settled on fines for Cruz Verde totalling approximately $84,500 USD. Colombian media has reported that the pharmacy has already begun the process of appealing the fine, arguing that their chain has always respected the price limits set forth by the country’s guidelines.
Cruz Verde was embroiled in a similar price-fixing scheme in Chile between 2007 and 2008 in conjunction with fellow drug-store chains Farmacias Ahumada and Salcobrand, with the firm paying a total of 13 million pesos to Chile’s government.
Full Content: El Ciudadano
Want more news? Subscribe to CPI’s free daily newsletter for more headlines and updates on antitrust developments around the world.
Featured News
Paramount and Skydance Agee to Merge in 2.4B Deal
Jul 8, 2024 by
CPI
Netflix and Other Streaming Giants Challenge Canadian Rules on News Funding
Jul 7, 2024 by
CPI
Watchdog Urges Colorado Investigation into Potential Rent Price Collusion
Jul 7, 2024 by
CPI
Antitrust Battle Looms Over Apple’s Lucrative Safari Deal with Google
Jul 7, 2024 by
CPI
Zimbrón Rejoins Cleary Gottlieb Steen & Hamilton as Antitrust Partner in London
Jul 7, 2024 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Private Equity Roll-Up Schemes
Jun 28, 2024 by
CPI
The FTC’s Focus on Private Equity is Warranted
Jun 28, 2024 by
CPI
Unraveling the Roll-Up: Private Equity’s Misunderstood Investment Strategy
Jun 28, 2024 by
CPI
Antitrust Focus on Private Equity Funds and Serial Acquisitions
Jun 28, 2024 by
CPI
Private Equity Roll-Ups Amidst Heightened Antitrust Enforcement
Jun 28, 2024 by
CPI